Inpart Logo
LoginRegister
ICO
Closed:

Novel Therapeutic Approaches Targeting Microglia Biology for Neuroinflammatory Disorders

Header

Astellas Pharma Inc. are an international pharmaceutical company seeking novel research programs targeting microglia biology for neuroinflammatory and/or neuroimmunological disorders. Astellas are interested in microglia biology with a focus on disease/pathophysiology-specific microglia. This could include aspects of the following, as well as other microglia‑specific disease traits:

  • Lysosomal function
  • Pyroptosis
  • Autoimmune/inflammatory diseases

Target Diseases

Diseases of particular interest are neuroinflammatory disorders which have a strong/clear relevance...

Opportunity types being sought:

  • Technology

  • Research Project

  • Spinout Company

  • Academic Researcher

  • Centre of Excellence

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile
Powered ByInpart
An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.